Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€252k

Latest filing published 19 Mar 2026 for Revolution Medicines, Inc., €174k.

Filing timeline

BuySale
Xiaolin Wang

Insider track record

Disclosed buys
0
Disclosed sells
9

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Xiaolin Wang: trading record in brief

Xiaolin Wang discloses dealings in Revolution Medicines, Inc. to SEC (Form 4). We count 16 filings; the first trade dates from 4 March 2021 and the latest from 17 March 2026.

Every open-market trade on record is a sale: 9 sales worth €252k. Besides market trades, the filings include 6 share grants. In 2026 alone, the filings show no purchases and 1 sale.

The newest entry dates from 19 March 2026: an open-market sale of €174k, in Revolution Medicines, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Xiaolin Wang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations